NCT00152919View on ClinicalTrials.gov

Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Prostatic Neoplasms
Interventions
DRUG

Meloxicam

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00152919 - Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy | Biotech Hunter | Biotech Hunter